United Therapeutics EVP, General Counsel Paul A. Mahon disposes of USD 4.12 million in common shares

• Paul A. Mahon, EVP and general counsel, exercised stock options for 8,300 shares at $146.03 on Sept. 17.
• He sold 8,300 shares of common stock in several trades at weighted-average prices ranging from $495.97 to $501.58.
• Beneficial ownership fell to 45,172 shares following the transactions.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. United Therapeutics Corporation published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001231589-26-000020), on September 18, 2026, and is solely responsible for the information contained therein.